Sort
50,496 grants matching “lung cancer”
Leveraging Diversity in Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores
$979,999David V Conti · University Of Southern California · U01 · FY2023 · CA
TempO-Seq for Preserved Tissues in Toxicity Testing Phase II
$979,864Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2017 · ES
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$979,825Robert A Salata · Case Western Reserve University · U54 · FY2023 · CA
PLCO EEMS and Extended Follow Up
$979,773Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer
$979,536Anita Bellail · Hb Therapeutics, Inc. · R44 · FY2023 · CA
Prospective Studies of Diet and Cancer in the AARP Cohort
$978,928Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Humanization, Production, and PK/PD Characterization of anti-TIP1 antibody against Non-Small Cell Lung Cancer
$978,235Sapna Deore · Medical Guidance Systems, Llc · R44 · FY2020 · CA
Peptide-based ELISA for laboratory diagnosis of sarcoidosis
$978,191Andrew E. Levin · Kephera Diagnostics, Llc · R44 · FY2025 · HL
National Resource for Translational and Developmental Proteomics
$977,670Neil L Kelleher · Northwestern University · P41 · FY2019 · GM
Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial
$977,596Kathryn H. Schmitz · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Clinical Utility of Salivary ExRNA Biomarkers for Gastric Cancer Detection
$977,588David T Wong · University Of California Los Angeles · UH3 · FY2016 · TR
Integrated analyses of genetics, epigenetics, and gene expression
$977,108Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2016 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER
$976,974Dana-Farber Cancer Institute · U01 · FY2002 · CA
DIESEL PARTICLE EXPOSURE AND LUNG CANCER
$976,949Brigham And Women'S Hospital · R01 · FY2004 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$976,871Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Promoting follow-up of abnormal cancer screening tests using population-basedsystems to support stepped care multilevel intervention
$976,725Jennifer S Haas · Massachusetts General Hospital · U01 · FY2018 · CA
MycoMEIA - Urine Diagnostic for Aspergillosis
$976,576Kieren A. Marr · Pearl Diagnostics, Inc. · R44 · FY2021 · AI
Exisulind for Chemoprevention of Lung Cancer
$976,569H. Lee Moffitt Cancer Ctr &Res Inst · U01 · FY2003 · CA
Bay Area Cancer Target Discovery and Development
$976,551Michael T McManus · University Of California, San Francisco · U01 · FY2023 · CA
DCTD Human Toxicology and Pharmacology
$976,485David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
Alveolar Tissuegenesis in Murine Acute Lung Injury
$976,312William J. Martin · Environmental Health Sciences · Z01 · FY2007 · ES
Studies of Occupational Cancer (Pesticides)
$975,974Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Empathic Communication Skills Training to Reduce Lung Cancer Stigma
$975,561Smita Banerjee · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial
$975,560Kathryn H. Schmitz · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Stromal Regulation of Bone Metastasis
$975,515Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA